Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Like a lot more
Future research directions include longitudinal studies on digital wellness interventions and age-specific impact assessments
Connor TJ (2004) Methylenedioxymethamphetamine (MDMA, ecstasy): a stressor on the immune system
N Engl J Med 392(6):612615 Rosenstock J, Frias J, Jastreboff AM, Du Y, Lou J, Gurbuz S, Thomas MK, Hartman ML, Haupt A, Milicevic Z, Coskun T (2023) Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Circulation 109 , 433438 (2004)
US$ 27.37
00217-5/asset/1d7305c6-2436-491d-bc41-6b556b89646a/main.assets/gr1.jpg)
US$ 28.09
US$ 27.88
